Continuing Review. Require its Research Personnel to provide any information about conduct of the Research at the Relying Institution that the Reviewing IRB requires for continuing review.
Continuing Review. From and subsequent to the date hereof, CVBG will have: (1) given to GCBS and its counsel and accountants access to their premises and books and records during normal business hours for any reasonable purpose related to the transactions contemplated hereby; and (2) cooperate and instruct CVBG’s counsel and accountants to cooperate with GCBS and with GCBS’s counsel and accountants with regard to the formulation and production of all necessary information, disclosures, financial statements, registration statements, and regulatory filings with respect to the transactions encompassed by this Agreement.
Continuing Review. Subject to applicable Laws, Nova shall continue to make available and cause to be made available to Allana and Allana’s agents and advisors all documents, agreements, corporate records and minute books as may be necessary to enable Allana to effect a thorough examination of Nova, the Nova Subsidiary and the business, properties and financial status thereof, and shall cooperate with Allana in securing access for Allana to any documents, agreements, corporate records or minute books not in the possession or under the control of Nova. Subject to applicable Laws, upon reasonable notice, Nova shall, and shall cause the Nova Subsidiary to, afford the officers, employees, counsel, accountants and other authorized representatives and advisors of Allana reasonable access, during normal business hours from the date hereof until the earlier of the Effective Date and the termination of this Agreement, to the properties books, contracts and records as well as to the management personnel of Nova, the Nova Subsidiary, and during such period, Nova shall, and shall cause the Nova Subsidiary to, furnish promptly to Allana all information concerning the business, properties and personnel of Nova and the Nova Subsidiary as Allana may reasonably request, except as limited by any applicable privacy laws.
Continuing Review. Subject to applicable Laws, Bradstone shall continue to make available and cause to be made available to HPB and its agents and advisors all documents, agreements, corporate records and minute books as may be necessary to enable HPB to effect a thorough examination of Bradstone and the business, properties and financial status thereof, and shall cooperate with HPB in securing access for HPB to any documents, agreements, corporate records or minute books not in the possession or under the control of Bradstone. Subject to applicable Laws, upon reasonable notice, Bradstone shall afford the officers, employees, counsel, accountants and other authorized representatives and advisors of HPB reasonable access, during normal business hours from the date hereof until the earlier of the Effective Time and the termination of this Agreement, to the properties, books, contracts and records as well as to the management personnel of Bradstone and during such period, Bradstone shall furnish promptly to HPB all information concerning the business, properties and personnel of Bradstone s as HPB may reasonably request, except as limited by any applicable privacy laws.
Continuing Review. The parties agree that they will constantly keep the performance of this Agreement under review with quarterly contract performance review meetings to discuss volumes and progress on quality.
Continuing Review. As required, continuing review of approved research will be initiated by the IRB of Record, who shall remain responsible for determining the frequency and extent of continuing review for each study as adequate to ensure the continued protection of the rights and welfare of research subjects. The period of continuing review shall not exceed twelve months from the date of IRB approval. The PI must submit documentation of this substantive review and outcome, as conducted by the IRB of record. References: VHA Handbook 1200.5 Considerations Document: CITI Use of Central IRBs in Multicenter Clinical Trials FDA Information Sheet, Non-Local IRB Review (1998) OHRP Guidance, IRB Knowledge of Local Research Context, August 27, 2998 (updated July 21, 2000) 45 CFR 46.103(b)(2), 45 CFR 46.103(d), 45 CFR 46.109(d), 45 CFR 46.114, 21 CFR 56.109(e), 21 CFR 56.114 NIH: Policy on the Use of a Single Institutional Review Board for Multi-Site Research (June 20, 2016)ETSU IRB Policy 10 FDA Guidance for Industry: Using A Centralized IRB Review Process in Multicenter Clinical Trials, March 2006 21 CFR 312.53 (Investigational New Drug Application 2016), Form FDA 1572 attestations, 21 CFR 812.43(c)(4)(i) (Investigational Device Exemptions 2016) Determination of Exception to the Required Use of a Single IRB for Certain HHS Cooperative Research that is Subject to the 2018 Requirements Related resources:
Continuing Review. A Relying Institution will Rrequire its Research Personnel to provide any information about conduct of the Research atconducted under the authority of the Relying Institution that the Reviewing IRB requires for continuing reviews. of the Research (when applicable).
Continuing Review. Subject to applicable Laws, HPB and Subco shall continue to make available and cause to be made available to Bradstone and its agents and advisors all documents, agreements, corporate records and minute books as may be necessary to enable Bradstone to effect a thorough examination of HPB and Subco and the business, properties and financial status thereof, and shall cooperate with Bradstone in securing access for Bradstone to any documents, agreements, corporate records or minute books not in the possession or under the control of HPB. Subject to applicable Laws, upon reasonable notice, HPB shall afford the officers, employees, counsel, accountants and other authorized representatives and advisors of Bradstone reasonable access, during normal business hours from the date hereof until the earlier of the Effective Time and the termination of this Agreement, to the properties, books, contracts and records as well as to the management personnel of HPB and during such period, HPB and Subco shall furnish promptly to Bradstone all information concerning the business, properties and personnel of HPB and Subco as Bradstone may reasonably request, except as limited by any applicable privacy laws.
Continuing Review. After the implementation and transition period, the Committee will meet on a bi-monthly basis or such other intervals as may be agreed by the Committee to discuss and review continuing issues which may include, without limitation:
Continuing Review. Subject to applicable Laws, upon reasonable notice, NWT shall continue to make available and cause to be made available to Nu-Mex and the agents and advisors thereto all documents, agreements, corporate records and minute books as may be reasonably necessary to enable Nu-Mex to effect a thorough examination of NWT and the NWT Subsidiaries and the business, properties and financial status thereof, and shall cooperate with Nu-Mex in securing reasonable access for Nu-Mex to any documents, agreements, corporate records or minute books not in the possession or under the control of NWT. Subject to applicable Laws, upon reasonable notice, NWT shall, and shall cause the NWT Subsidiaries to, afford officers, employees, counsel, accountants and other authorized representatives and advisors of Nu-Mex reasonable access, during normal business hours from the date hereof until the earlier of the Effective Time or the termination of this Agreement, to the properties, books, contracts and records as well as to the management personnel of NWT and the NWT Subsidiaries and, during such period, NWT shall, and shall cause the NWT Subsidiaries to, furnish promptly to Nu-Mex all information concerning the business, properties and personnel of NWT and the NWT Subsidiaries as Nu-Mex may reasonably request, except as limited by any applicable privacy laws. Nothing in the foregoing shall require NWT or the NWT Subsidiaries to disclose information subject to a written confidentiality agreement with any Person.
